CD248 and neoplasm: Total of 185 patients (Figure 3G and H; Supplementary Figure 3G and H), of which 94 (51%) displayed endosialin expression in tumour cells, 107 (58%) had endosialin-positive stromal fibroblasts and 60/61 (98%) patients who had samples with detectable vasculature had endosialin-positive pericytes.